Nomex (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride is a selective alpha‑adrenergic agonist. By stimulating α1 and α2 receptors on the blood vessels of the nasal mucosa, it causes vasoconstriction, which reduces capillary engorgement and interstitial fluid. This decreases mucosal edema and opens the nasal airway.

The appropriate dose of Nomex is determined by a qualified healthcare professional based on the patient’s age, condition, and response. The prescriber will provide specific instructions on the number of sprays per nostril and the maximum duration of therapy.

Safety data for Xylometazoline Hydrochloride in pregnancy and lactation are limited. The product is classified as pregnancy category unknown. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Nomex.

To order Nomex, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nomex (Xylometazoline) and other imidazoline decongestants such as oxymetazoline share a similar mechanism of selective α‑adrenergic vasoconstriction. Xylometazoline typically has a rapid onset and a duration of action of 6‑8 hours, comparable to oxymetazoline, but individual response and tolerability may vary.

Nomex should be stored at room temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct heat, and ensure the spray tip is clean and capped when not in use to maintain sterility.

Nomex is administered as a nasal spray. The usual instruction is to gently blow the nose, tilt the head slightly forward, insert the nozzle into one nostril, and spray the prescribed number of sprays while breathing in gently. Repeat in the other nostril if directed by the prescriber.

Serious adverse reactions, although rare, include severe hypertension, nasal ulceration or necrosis, anaphylactic shock, and rebound congestion (rhinitis medicamentosa) after prolonged use. Patients should seek immediate medical attention if they experience rapid heartbeat, chest pain, severe headache, or signs of an allergic reaction.

Nomex should be avoided in individuals with known hypersensitivity to Xylometazoline or any excipients, in patients with severe hypertension or uncontrolled cardiovascular disease, and in infants younger than the age specified on the product label (typically under 2 years). Consultation with a healthcare professional is essential before use.